October 17, 2011, Philadelphia, PA
Register by 9/16/11 and receive up to $200 off!
Download Asthma and COPD Brochure
Free downloads available!
Access our Asthma and COPD Resources.
Become a Pharma IQ Member and receive our weekly newsletter!
Connect to a global Pharma IQ social network
Read More about sponsoring Asthma & COPD.
Mark Your Calendar
Tell a Colleague
Asthma affects an estimated 235 million people globally, and as that number grows, so does the demand for drugs to cope with the illness.
GlobalData, a London-based research firm, says the global asthma market will expand from around $12.4 billion in 2009 to $14 billion by 2017.
Its November 2010 report stated that “competition in the asthma market is becoming intense” as a result of the emergence of new treatment options. In fact, GlobalData identified no fewer than 229 molecules in the pharmaceutical pipeline in development against asthma.
The 3rd Asthma & COPD provides you with an opportunity to take control of the market by improving competitiveness through targeted delivery to increase bioavailability of therapeutics and reduce the attrition rate. Here you will also gain insight into reformulating approved drugs as patents expire.
Stakeholders from all aspects of asthma and COPD, including Directors, Heads, Scientists, Research Leaders and Mangersworking in:
Past attendees say IQPC Pharma events are:
One of the best conferences I have attended
Timely presentations and points raised.
[ Register Now ]
Questions about IQPC's Conferences, Events or Training Seminars? Contact us on 1-800-882-8684 or email email@example.com now!